Bruker completes acquisition of 80% majority interest in Hain Lifescience

Bruker Corporation completed the acquisition of an 80% majority interest in Hain Lifescience GmbH, a molecular diagnostics company based in Nehren, Germany.

“Bruker Corporation today announced that is has completed the acquisition of an 80% majority interest in Hain Lifescience GmbH, based in Nehren, Germany.”prnewswire.com

• 1 source
• prnewswire.comBruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbHBruker CorporationOct 16, 2018

Summarized from public sources; check the original articles before acting on it.